PRMT1 and cancer: In line with these results, we showed in this work that ectopic expression of PRMT1 in MCF-10A cells evidently elevated the percentage of cancer stem cell (CSC)-like cells that exhibit a CD44high/CD24low antigenic phenotype and efficient mammosphere-formation ability.